Sign in

    Bill Stein

    Research Analyst at Celadon Financial

    Bill Stein is a Research Analyst at Celadon Financial who has participated in earnings calls with coverage that includes companies such as Origin Agritech. While his coverage list appears limited, he has engaged directly with corporate management, reflecting an active role in financial due diligence. Information on his performance metrics, success rates, or rankings on platforms like TipRanks is not available, suggesting a profile with limited public investment track record. Details on prior experience, the start of his career, or professional credentials such as FINRA registrations or specific securities licenses are not currently accessible.

    Bill Stein's questions to Origin Agritech (SEED) leadership

    Bill Stein's questions to Origin Agritech (SEED) leadership • Q2 2022

    Question

    Bill Stein of Celadon Financial inquired about Origin Agritech's patent filing strategy for its gene-editing technology, its licensing relationship with DuPont, expectations for new corn contracts, and the company's current competitive strength compared to its history.

    Answer

    Chairman and CEO Gengchen Han confirmed that the company is filing for worldwide patents for its gene-editing technology, noting a significant breakthrough in corn. He explained that while open to collaborations, the focus is on local Chinese companies over multinationals like DuPont. Dr. Han asserted that Origin is much stronger now due to advanced technology, a robust GMO product pool, and the unique, high-potential nutrition-enhanced corn (NEC) business. Director of IR Joe Ramelli added that management plans to increase investor communication.

    Ask Fintool Equity Research AI